Leire Agirre‐Garrido

机构：Barcelona Institute for Global Health, Universitat de Barcelona · ORCID：0009-0003-6453-2815

发表论文 9 篇 · 总被引 63 次 · h-index 5

代表论文

• Reviewing MAESTRO-NASH and the implications for hepatology and health systems in implementation/accessibility of Resmetirom (2025 · npj gut and liver. · 被引 19)
• Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries (2025 · Clinical Gastroenterology and Hepatology · 被引 16)
• Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes (2025 · JAMA Network Open · 被引 10)
• Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 9)
• A call to action to address the steatotic liver disease public health threat in Barcelona (2025 · The Lancet Regional Health - Europe · 被引 7)
• Cost of Metabolic Dysfunction‐Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries (2025 · Liver International · 被引 3)